title: Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B.
authors.affiliation: Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, USA.
authors.forename: S R
authors.initials: SR
authors.lastname: Virata
authors.forename: J A
authors.initials: JA
authors.lastname: Kylstra
authors.forename: J C
authors.initials: JC
authors.lastname: Brown
authors.forename: D A
authors.initials: DA
authors.lastname: Wohl
authors.forename: M S
authors.initials: MS
authors.lastname: Cohen
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D004338:Drug Combinations; D009877:Endophthalmitis / Q000188:drug therapy* / Q000382:microbiology; D015821:Eye Infections, Fungal / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010715:Phosphatidylglycerols / Q000627:therapeutic use*
chemical_list: D000935:Antifungal Agents; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D000666:Amphotericin B